A Phase 1, Single-centre, Double-blind Study of Pexiganan Cream (Locilex) in Healthy Adult Subjects

Trial Profile

A Phase 1, Single-centre, Double-blind Study of Pexiganan Cream (Locilex) in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2014

At a glance

  • Drugs Pexiganan (Primary)
  • Indications Diabetic foot ulcer; Skin and soft tissue infections
  • Focus Adverse reactions
  • Sponsors Dipexium Pharmaceuticals
  • Most Recent Events

    • 25 Jul 2014 New trial record
    • 17 Jul 2014 Results published in the Dipexium Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top